Bloomage BioTech addresses the ongoing debate around recombinant collagen, making it clear that the company opposes the misleading use of the term 'recombinant' collagen in marketing, rather than the legitimate scientific research and industrial applications of collagen. The company underscores that the reputation of domestic brands should not rest on the misuse of scientific concepts and urges the industry to focus on product quality and innovative solutions.